KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Cash from Operations (2017 - 2025)

Historic Cash from Operations for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $1.8 million.

  • Cardlytics' Cash from Operations rose 2714.8% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$741000.0, marking a year-over-year increase of 9164.51%. This contributed to the annual value of -$8.8 million for FY2024, which is 466972.97% down from last year.
  • As of Q3 2025, Cardlytics' Cash from Operations stood at $1.8 million, which was up 2714.8% from $1.2 million recorded in Q2 2025.
  • Over the past 5 years, Cardlytics' Cash from Operations peaked at $5.8 million during Q2 2023, and registered a low of -$19.7 million during Q1 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$6.7 million (2022), whereas its average is -$5.5 million.
  • Per our database at Business Quant, Cardlytics' Cash from Operations plummeted by 226054.05% in 2022 and then surged by 18611.86% in 2023.
  • Cardlytics' Cash from Operations (Quarter) stood at -$555000.0 in 2021, then crashed by 2260.54% to -$13.1 million in 2022, then soared by 122.4% to $2.9 million in 2023, then rose by 1.53% to $3.0 million in 2024, then tumbled by 40.89% to $1.8 million in 2025.
  • Its Cash from Operations was $1.8 million in Q3 2025, compared to $1.2 million in Q2 2025 and -$6.7 million in Q1 2025.